Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 HKD | +2.35% | +0.99% | -18.23% |
Business Summary
Number of employees: 5,270
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology Drugs
34.5
%
| 2,681 | 38.5 % | 2,345 | 34.5 % | -12.54% |
Central Nervous System Drugs
27.6
%
| 1,538 | 22.1 % | 1,873 | 27.6 % | +21.74% |
Cardiovascular System Drugs
27.5
%
| 1,786 | 25.7 % | 1,865 | 27.5 % | +4.41% |
Alimentary Tract and Metabolism Drugs
7.3
%
| 735 | 10.6 % | 498 | 7.3 % | -32.32% |
Others
3.1
%
| 215 | 3.1 % | 208 | 3.1 % | -3.29% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
81.9
%
| 5,851 | 84.1 % | 5,558 | 81.9 % | -5.01% |
European Union
7.3
%
| 360 | 5.2 % | 497 | 7.3 % | +38.30% |
Asia (Other than China)
7.3
%
| 398 | 5.7 % | 494 | 7.3 % | +23.95% |
Other Countries
3.5
%
| 348 | 5.0 % | 240 | 3.5 % | -31.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Yun Li Xue
PRN | Corporate Officer/Principal | 60 | 94-06-07 |
Mei Yi Lee
SEC | Corporate Secretary | 56 | 20-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Xian Yuan
BRD | Director/Board Member | 65 | 94-06-07 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
Hua Qiao Zhang
BRD | Director/Board Member | 60 | 14-05-31 |
Man Kit Leung
BRD | Director/Board Member | 71 | 14-05-31 |
Yuk Lam Lo
BRD | Director/Board Member | 76 | 14-05-31 |
Sze Chung Choy
BRD | Director/Board Member | 65 | 14-05-31 |
Rui Lin Song
BRD | Director/Board Member | 61 | 17-03-28 |
Yuan Yuan Zhu
BRD | Director/Board Member | 43 | 09-07-31 |
Lin Xia
BRD | Director/Board Member | 67 | 23-05-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,761,670,643 | 1,950,149,832 ( 51.84 %) | 0 | 51.84 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
360,596,456 | 70.81% | 465,349,726 $ |
Company contact information
Luye Pharma Group Ltd.
No. 15 Chuang Ye Road High-Tech Industrial Development Zon
264003, Yantai
+
http://www.luye.cnSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.23% | 1.43B | |
+33.04% | 698B | |
+26.51% | 568B | |
-4.32% | 358B | |
+18.98% | 328B | |
+3.81% | 283B | |
+16.28% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+7.36% | 165B |
- Stock Market
- Equities
- 2186 Stock
- Company Luye Pharma Group Ltd.